- At the outset, let’s not beat around the bush by feigning ignorance about how maintaining a healthy weight, bodily disposition, and presentable demeanor has become non-negotiable over the last few decades. One may term it the incessant bombardment of advertisements, the judiciously effective dissemination of information about the perils of being overweight, and the improved acceptance of maintaining an ideal body weight, combined with a healthy lifestyle, a welcome mantra for most of us. Of course, the skincare, healthcare, and general well-being industries are inour face most of the time, endorsed by some of the biggest names in entertainment and sports, reminding us of the need for the modern world’s outlook on the matter.
PC: The Indian Express
- Trust, who would not wish to be endowed with a healthy outlook, well sculpted/chiseled physical appearance, energetic/enthusiastic personality, and amazing spring in the steps, with an ability to take on the challenges of the world with panache. Without batting an eyelid, it can be vouched that all of us wish to be just like the way it is mentioned here. As healthcare/medicine makes tremendous progress, the once-impossible task of reducing body weight through injection or oral medication is gaining traction in recent years. One may call it a boon or a bane, depending on one’s perception. Nonetheless, what cannot be discounted is that many people willingly seek the magic potion to lose weight. Now, the wonder drug has reached the shores of India, too.
PC: Brain & Life
- As newspaper reports suggest, semaglutide goes off patent in India, the plot surrounding the magic drug thickens. Let’s dwelve to comprehend further. For the uninitiated, semaglutide is a prescription medication used to manage type 2 diabetes, promote weight loss, and reduce cardiovascular risk. It functions as a GLP-1 receptor agonist, mimicking a hormone that stimulates insulin production, lowers blood sugar, reduces hunger, and slows digestion. In other words, helps reduce unhealthy weight. Mind you, aspiration has a new face and waistline. America’s Ozempic revolution appears poised to reach India, where the semaglutide patent has just expired. It’s the key molecule in GLP-1 weight-loss drugs. One in eight adult Americans is taking such drugs already.
PC: Healthwire
- Herein lies the catch. If lower costs help make these as popular here, too, yes, those thousands of crores in revenue could add up quickly. Imagine one injection to replace a long-winded process to possess a near-perfect body without worrying about regular visits to the gym and following a strict diet. How one feels the magic drug as a blessing that can be ours for a few hundred rupees a month, without suffering, seems surreal to believe. However, these are not cosmetic drugs. Semaglutide is being called a statin moment for metabolism; it’s that serious. It must be prescribed carefully and managed carefully, too. Don’t forget, we are jugaad masters. As such, between over-eager sellers and buyers, it’s over to the doctors and regulators to hit the safety brakes.
